Lunch Innovation Theater (Non-Accredited): The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD)

Lunch will be served. Seating is limited to 300 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Eric Thomason, MSN, PMHNP-BC, MBA

This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck.